根治切除可能な4型・大型3型胃癌に対する術前化学放射線療法第II相試験(OGSG1205)
2019
Stage III胃癌に対するadjuvant DTX+S-1療法の長期生存解析-OGSGのPII試験より- Long-term survival analysis of adjuvant S-1 plus docetaxel chemotherapy for Stage III gastric cancer after curative D2 gastrectomy (OGSG0604 & OGSG1002)
Phase II study of panitumumab monotherapy in chemotherapy-naïve frail or elderly patients with unresectable, RAS wild type colorectal cancer （OGSG1602）
A phase II trial of low-dose nab-paclitaxel for patients with previously treated or recurrent advanced gastric cancer (OGSG1302)
Comparing five-weekly S-1 plus cisplatin with tri-weekly capecitabine plus cisplatin in patients with HER2 negative recurrent gastric cancer after S-1 adjuvant therapy or chemotherapy naïve advanced gastric cancer: a pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials
Phase II study of 5‑fluorouracil–leucovorin plus bevacizumab for chemotherapy‑naïve older or frail patients with metastatic colorectal cancer (OGSG 0802)
First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602
A Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)